Highbridge Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-23,070
Closed -$1.02M 1580
2017
Q4
$1.02M Buy
+23,070
New +$1.05M 0.02% 564
2016
Q3
Sell
-28,003
Closed -$1.55M 1604
2016
Q2
$1.55M Buy
+28,003
New +$1.54M 0.03% 501
2013
Q4
Sell
-38,352
Closed -$1.16M 1268
2013
Q3
$1.16M Buy
38,352
+28,677
+296% +$938K 0.01% 637
2013
Q2
$283K Buy
+9,675
New +$273K ﹤0.01% 1058

Other funds holding PBH

Highbridge Capital Management's PBH Position: Q1 2018 in Review

Highbridge Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2018, closing a stake of 23,070 shares — an estimated $1.02M sold.

Highbridge Capital Management first reported a position in PBH in Q2 2013 and held it in 4 quarters. The position peaked at $1.55M in Q2 2016. 239 funds tracked by Wall St. Rank hold PBH as of Q1 2018.

  • Highbridge Capital Management reported no remaining Prestige Consumer Healthcare position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 23,070 Prestige Consumer Healthcare shares in Q1 2018, an estimated $1.02M.
  • Highbridge Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 4 quarters.
  • Highbridge Capital Management's Prestige Consumer Healthcare position peaked at $1.55M in Q2 2016.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.